India has been at the forefront of headlines surrounding Covid-19 (coronavirus) this year, as the highly populous country has grappled with the fast-spreading pandemic and its volatile transmission.
Oxygen provision has been a particular talking point throughout as India, like so many other countries around the world, faced challenges in ensuring medical oxygen supply during peak periods of patient demand.
India appeared to take something of a lead in April when its Government granted temporary permission for manufacturers of industrial oxygen to manufacture and sell the gas for medical use, as cases and hospital admissions continued to escalate.
gasworld understood the proposal was put forward by the All India Industrial Gases Manufacturer’s Association (AIIGMA), to ensure the availability and supply of oxygen for medical use across the country.
The grant was issued by the Directorate General of Health Services (Government of India) and essentially enabled all manufacturers of industrial oxygen in the country to obtain a license to sell the product for medical use within 24 hours of their application being received.
... to continue reading you must be a member